Predicta Biosciences: $23.4 Million Series A Raised To Advance Diagnostic And Therapeutic Discovery Tools
By Amit Chowdhry ● Oct 7, 2025
Predicta Biosciences, a precision oncology company focused on developing advanced diagnostic and therapeutic discovery tools, has announced the close of a $23.4 million Series A funding round. The funding round was oversubscribed and led by Engine Ventures, with participation from Illumina Ventures, Lightchain Capital, Mass General Brigham Ventures, ACS BrightEdge, Binney Street Capital of Dana-Farber Cancer Institute, and Myeloma Solutions Fund.